Daniel Bee Email & Phone Number

Newton Abbot, Devon, Gb

Novel POCT digital diagnostic technology

Flémalle-Grande, Walloon Region, Be

Revolutionising bone regeneration for dental surgery through the development of superior bone graft technologies

Cambridge, Gb

Wellcome Sanger Institute - The world's largest and most comprehensive resource for exploring the impact of somatic mutations in human cancer.

Bourton On The Water, England, Gb

A global manufacturer and innovator of proprietary sterile, single use orthopaedic, sports medicine and surgical devices. Commercial partnerships with multiple Global OEMs• Attained UK, Germany, USA and International market leadership in multiple product categories.M&A and rapid organic growth.• Trade sales of two non-core French and German manufacturing subsidiariesFund-raising and exit• Fund-raising – led two bank refinancing processesLed exit for The Riverside Company via an SBO, supported by Apposite Capital, March 2018.

UK independent distributor sales to spine and orthopaedic surgical markets • Rapid revenue growth - attained market leadership in neonatal spine implants.• Secured an exit for LivingBridge Private Equity.

London, Gb

Advising BBC Dragon James Caan’s portfolio companies to maximise growth and optimise exit value.

Kuala Lumpur, My

• Angel investment backed R&D biotech company• Led the full commercial roll-out - established international sales across EU and Far East• Secured a trade sale to a global pharmaceutical company (InQpharm)

Bourton On The Water, England, Gb

Advised on commercial strategy and conducted commercial DD on a number of overseas M&A targets

Malvern, Pa, Us

Biotech and digital health company focused on developing and commercialising proprietary biocides that safely, effectively, and naturally kill contagious pathogens. • UK and International growth – 330% sales growth in 48 months • Achieved growth through NPD and cultivating a high-performing, customer-centric sales team. • M&A - acquisition and integration of Labcaire Ltd • Secured a cross-border strategic exit for the entire UK trading entity.

Lewisville, Tx, Us

• UK & International Commercial growth - Anaesthesia, neo-natal, orthopaedics• $220m P&L Accountability• Recovered market leadership through strategic re-orientation and a instilling a confident, sales driven culture.- Investors in People Award

Boston, Ma, Us

Cardiovascular & Haematology - donor and surgical automated blood processing technology - 174% sales growth - 48 months of successive quarter on quarter growth- 740% EBITDA growth- 33% return on Sales (up from 8% return on sales in 2001)- Exceeded revenue and EBITDA targets for 16 consecutive quarters

Lakewood, Colorado, Us

Blood component and Digital Health Spin-out from SAAB Aerospace (Sweden)• Medical Technology Spin-out from SAAB Aerospace• Led the International commercialisation of the business across Europe, Australia and USA.• Secured a strategic exit to Gambro BCT

Bourton On The Water, England, Gb

• Surgical, orthopaedic, spinal implant, wound care and blood products.• 14x revenue growth through NPD, manufacturing and commercial agreements with global partners.

Fellowship, Chartered Marketeer

Bachelor'S Degree, Business And Finance

Education record

Chartered Director, Diploma In Company Direction

Education record